Skip to main content

Peer Review reports

From: The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial

Original Submission
23 Aug 2023 Submitted Original manuscript
27 Nov 2023 Reviewed Reviewer Report
14 Dec 2023 Reviewed Reviewer Report
25 Dec 2023 Reviewed Reviewer Report
4 Feb 2024 Author responded Author comments - Charlie Welch
Resubmission - Version 2
4 Feb 2024 Submitted Manuscript version 2
7 Feb 2024 Author responded Author comments - Charlie Welch
Resubmission - Version 3
7 Feb 2024 Submitted Manuscript version 3
27 Feb 2024 Reviewed Reviewer Report
1 Mar 2024 Reviewed Reviewer Report
3 Mar 2024 Reviewed Reviewer Report
15 Mar 2024 Author responded Author comments - Charlie Welch
Resubmission - Version 4
15 Mar 2024 Submitted Manuscript version 4
19 Mar 2024 Reviewed Reviewer Report
20 Mar 2024 Reviewed Reviewer Report
23 Mar 2024 Reviewed Reviewer Report
7 Apr 2024 Author responded Author comments - Charlie Welch
Resubmission - Version 5
7 Apr 2024 Submitted Manuscript version 5
Publishing
17 May 2024 Editorially accepted
19 Jul 2024 Article published 10.1186/s12874-024-02248-9

You can find further information about peer review here.

Back to article page